NMDA subunit antagonism reduces inflammatory pain in male and female rats

Correspondence: Dr Gabriel C Quintero Center for Neurosciences, INDICASAT-AIP, No. 219 Clayton, Ciudad del Saber, Panamá, Panamá Tel +1 507 397 9772 Fax +1 507 397 9772 Email gquintero2008@gmail.com Background: Studies have shown that N-methyl-D-aspartate (NMDA) receptors play a critical role in pain processing at different levels of the central nervous system. Methods: In this study, we used adult Wistar rats to examine gender differences in the effects of NR2B NMDA antagonism at the level of the anterior cingulate cortex in phasic pain, and in the first and second phases of a formalin test. Rats underwent stereotactic surgery for cannula implantation in the anterior cingulate cortex. After recovery, paw withdrawal latency to a noxious thermal stimulus was assessed. Rats were also subjected to a formalin pain test whereby 60 μL of 5% formalin was injected into the right hind paw. Results: Female and male rats that received Ro 25-6981, an NR2B antagonist, before formalin injection showed significantly reduced pain responses to the formalin test compared with salineinjected control rats (P , 0.05). No gender differences in phasic pain responses were found in rats treated with Ro 25-6981. Conclusion: These results suggest that cortical antagonism of the NR2B subunit reduces inflammatory pain levels in both genders of rat.